Stock News

Burns J W & Co Has Lifted By $372,297 Its Constellation Brands (STZ) Position; Bb Biotech Ag Has Boosted Its Esperion Therapeutics (ESPR) Position

Burns J W & Co Inc increased Constellation Brands (STZ) stake by 45.43% reported in 2017Q2 SEC filing. Burns J W & Co Inc acquired 1,929 shares as Constellation Brands (STZ)’s stock rose 13.40%. The Burns J W & Co Inc holds 6,175 shares with $1.20 million value, up from 4,246 last quarter. Constellation Brands now has $43.57 billion valuation. The stock increased 1.91% or $4.17 during the last trading session, reaching $222.75. About 1.32M shares traded or 5.21% up from the average. Constellation Brands, Inc. (NYSE:STZ) has risen 17.20% since December 15, 2016 and is uptrending. It has outperformed by 0.50% the S&P500.

Bb Biotech Ag increased Esperion Therapeutics Inc. (ESPR) stake by 7.45% reported in 2017Q2 SEC filing. Bb Biotech Ag acquired 105,000 shares as Esperion Therapeutics Inc. (ESPR)’s stock rose 33.24%. The Bb Biotech Ag holds 1.51 million shares with $70.05 million value, up from 1.41 million last quarter. Esperion Therapeutics Inc. now has $1.51B valuation. The stock increased 1.10% or $0.63 during the last trading session, reaching $57.76. About 772,328 shares traded or 50.49% up from the average. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since December 15, 2016 and is uptrending. It has outperformed by 117.05% the S&P500.

Bb Biotech Ag decreased Sage Therapeutics Inc. (NASDAQ:SAGE) stake by 65,000 shares to 907,439 valued at $72.27 million in 2017Q2. It also reduced Celgene Corp (NASDAQ:CELG) stake by 90,000 shares and now owns 3.25 million shares. Kite Pharma Inc. (NASDAQ:KITE) was reduced too.

Investors sentiment increased to 1.67 in 2017 Q2. Its up 0.45, from 1.22 in 2017Q1. It is positive, as 12 investors sold ESPR shares while 37 reduced holdings. 26 funds opened positions while 34 raised stakes. 19.33 million shares or 18.76% more from 16.28 million shares in 2017Q1 were reported. Meditor accumulated 566,000 shares or 3.94% of the stock. Equitec Proprietary Mkts Llc stated it has 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Quantbot Limited Partnership reported 0.01% stake. Aperio Grp Inc Ltd Liability Company has invested 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Quantitative Inv Management Ltd has 0.06% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 80,800 shares. Alliancebernstein Limited Partnership has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Northern Tru Corp has invested 0.01% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Bank & Trust Of Montreal Can holds 596 shares or 0% of its portfolio. Blackrock Incorporated accumulated 1.28M shares. Moreover, Clearbridge Invs Ltd Liability Co has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR). First Trust Advsrs Ltd Partnership holds 9,673 shares or 0% of its portfolio. Next Fincl Incorporated invested 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Price T Rowe Md reported 81,547 shares. Moreover, Discovery Mgmt Ltd Ct has 1.08% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 965,059 shares. Illinois-based Pentwater Mgmt LP has invested 0.81% in Esperion Therapeutics, Inc. (NASDAQ:ESPR).

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Esperion Therapeutics had 49 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Strong Buy” rating by Needham given on Wednesday, August 19. Barclays Capital maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Wednesday, February 24 with “Overweight” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, December 15 report. The stock has “Buy” rating by Needham on Wednesday, October 18. The company was maintained on Tuesday, September 29 by Chardan Capital Markets. The firm has “Neutral” rating given on Monday, March 20 by Credit Suisse. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Market Outperform” rating given on Wednesday, March 9 by JMP Securities. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Buy” rating given on Monday, June 26 by Stifel Nicolaus. As per Wednesday, June 29, the company rating was downgraded by Credit Suisse. JP Morgan downgraded Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Wednesday, June 29 to “Neutral” rating.

Since August 1, 2017, it had 0 buys, and 5 insider sales for $24.74 million activity. MULLIN THOMAS J had sold 50,000 shares worth $10.47M on Friday, October 13. Shares for $616,644 were sold by Newlands William A on Monday, October 9. FROMBERG BARRY A sold 2,500 shares worth $520,000. The insider Hackett William F. sold 12,517 shares worth $2.47M.

Investors sentiment decreased to 1.14 in 2017 Q2. Its down 0.02, from 1.16 in 2017Q1. It fall, as 42 investors sold STZ shares while 242 reduced holdings. 108 funds opened positions while 221 raised stakes. 143.15 million shares or 0.40% less from 143.73 million shares in 2017Q1 were reported. 18 are held by Tortoise Invest Ltd Liability Co. Badgley Phelps Bell reported 0.84% of its portfolio in Constellation Brands, Inc. (NYSE:STZ). Ibm Retirement Fund reported 3,959 shares or 0.16% of all its holdings. 96 are owned by Parkside Savings Bank And Tru. Financial Bank Of America De invested in 0.03% or 841,762 shares. Raymond James & Associates stated it has 0.03% in Constellation Brands, Inc. (NYSE:STZ). Tributary Ltd Liability Company accumulated 4,000 shares. Nine Chapters Capital Management Ltd Llc invested 2.94% in Constellation Brands, Inc. (NYSE:STZ). Cornerstone Advisors holds 0.21% of its portfolio in Constellation Brands, Inc. (NYSE:STZ) for 6,000 shares. Wellington Mngmt Group Inc Llp stated it has 1.69 million shares or 0.08% of all its holdings. Hoplite Cap Mngmt LP owns 447,288 shares. Amp Invsts holds 0.09% or 80,389 shares. Sigma Planning holds 0.11% of its portfolio in Constellation Brands, Inc. (NYSE:STZ) for 6,307 shares. Fincl Bank Of Nova Scotia owns 56,455 shares. Cantab Capital Llp holds 4,186 shares.

Among 22 analysts covering Constellation Brands (NYSE:STZ), 15 have Buy rating, 0 Sell and 7 Hold. Therefore 68% are positive. Constellation Brands had 69 analyst reports since August 27, 2015 according to SRatingsIntel. UBS maintained the shares of STZ in report on Thursday, October 6 with “Neutral” rating. As per Friday, June 30, the company rating was maintained by Wells Fargo. FinnCap maintained Constellation Brands, Inc. (NYSE:STZ) on Wednesday, September 16 with “Corporate” rating. The rating was initiated by Credit Suisse with “Neutral” on Friday, September 16. Wells Fargo initiated the shares of STZ in report on Tuesday, April 5 with “Outperform” rating. The firm earned “Outperform” rating on Tuesday, April 11 by Cowen & Co. The firm has “Buy” rating given on Monday, October 16 by Cowen & Co. The firm has “Buy” rating by Goldman Sachs given on Thursday, April 7. The stock has “Buy” rating by Pivotal Research on Thursday, June 29. The firm has “Buy” rating by Stifel Nicolaus given on Monday, September 18.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *